JP2017509351A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017509351A5 JP2017509351A5 JP2016561993A JP2016561993A JP2017509351A5 JP 2017509351 A5 JP2017509351 A5 JP 2017509351A5 JP 2016561993 A JP2016561993 A JP 2016561993A JP 2016561993 A JP2016561993 A JP 2016561993A JP 2017509351 A5 JP2017509351 A5 JP 2017509351A5
- Authority
- JP
- Japan
- Prior art keywords
- genes
- biological sample
- patient
- probes
- sample
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000623 proteins and genes Proteins 0.000 claims 34
- 238000000034 method Methods 0.000 claims 32
- 239000000523 sample Substances 0.000 claims 26
- 239000012472 biological sample Substances 0.000 claims 23
- 230000014509 gene expression Effects 0.000 claims 19
- 101000721757 Homo sapiens Olfactory receptor 51E2 Proteins 0.000 claims 14
- 102100025128 Olfactory receptor 51E2 Human genes 0.000 claims 14
- 102100040410 Alpha-methylacyl-CoA racemase Human genes 0.000 claims 12
- 108010044434 Alpha-methylacyl-CoA racemase Proteins 0.000 claims 12
- 206010060862 Prostate cancer Diseases 0.000 claims 11
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims 11
- 102100036618 ATP-binding cassette sub-family A member 13 Human genes 0.000 claims 7
- 102100022529 Cadherin-19 Human genes 0.000 claims 7
- 102100036217 Collagen alpha-1(X) chain Human genes 0.000 claims 7
- 102100028466 Frizzled-8 Human genes 0.000 claims 7
- 102100020759 Homeobox protein Hox-C4 Human genes 0.000 claims 7
- 101000929660 Homo sapiens ATP-binding cassette sub-family A member 13 Proteins 0.000 claims 7
- 101000899410 Homo sapiens Cadherin-19 Proteins 0.000 claims 7
- 101000875027 Homo sapiens Collagen alpha-1(X) chain Proteins 0.000 claims 7
- 101001061408 Homo sapiens Frizzled-8 Proteins 0.000 claims 7
- 101001002994 Homo sapiens Homeobox protein Hox-C4 Proteins 0.000 claims 7
- 101000990902 Homo sapiens Matrix metalloproteinase-9 Proteins 0.000 claims 7
- 101001064853 Homo sapiens Polyunsaturated fatty acid lipoxygenase ALOX15 Proteins 0.000 claims 7
- 101000613332 Homo sapiens Protocadherin gamma-A1 Proteins 0.000 claims 7
- 101000851593 Homo sapiens Separin Proteins 0.000 claims 7
- 102100030412 Matrix metalloproteinase-9 Human genes 0.000 claims 7
- 108091033411 PCA3 Proteins 0.000 claims 7
- 102100031950 Polyunsaturated fatty acid lipoxygenase ALOX15 Human genes 0.000 claims 7
- 102100040876 Protocadherin gamma-A1 Human genes 0.000 claims 7
- 102100036750 Separin Human genes 0.000 claims 7
- 101000882908 Homo sapiens Claudin-3 Proteins 0.000 claims 6
- 102100030760 Apolipoprotein F Human genes 0.000 claims 5
- 102100039888 Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase Human genes 0.000 claims 5
- 102100020683 Beta-klotho Human genes 0.000 claims 5
- 102100038423 Claudin-3 Human genes 0.000 claims 5
- 102100027367 Cysteine-rich secretory protein 3 Human genes 0.000 claims 5
- 102100040133 Free fatty acid receptor 2 Human genes 0.000 claims 5
- 102100030087 Homeobox protein DLX-1 Human genes 0.000 claims 5
- 102100027890 Homeobox protein Nkx-2.3 Human genes 0.000 claims 5
- 101000793431 Homo sapiens Apolipoprotein F Proteins 0.000 claims 5
- 101000887645 Homo sapiens Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase Proteins 0.000 claims 5
- 101001139095 Homo sapiens Beta-klotho Proteins 0.000 claims 5
- 101000726258 Homo sapiens Cysteine-rich secretory protein 3 Proteins 0.000 claims 5
- 101000890668 Homo sapiens Free fatty acid receptor 2 Proteins 0.000 claims 5
- 101000864690 Homo sapiens Homeobox protein DLX-1 Proteins 0.000 claims 5
- 101000632181 Homo sapiens Homeobox protein Nkx-2.3 Proteins 0.000 claims 5
- 101000979249 Homo sapiens Neuromodulin Proteins 0.000 claims 5
- 101001000368 Homo sapiens Proline, histidine and glycine-rich protein 1 Proteins 0.000 claims 5
- 101000616761 Homo sapiens Single-minded homolog 2 Proteins 0.000 claims 5
- 101000585049 Homo sapiens Syntaxin-19 Proteins 0.000 claims 5
- 101000633617 Homo sapiens Thrombospondin-4 Proteins 0.000 claims 5
- 101000844504 Homo sapiens Transient receptor potential cation channel subfamily M member 4 Proteins 0.000 claims 5
- 102100023206 Neuromodulin Human genes 0.000 claims 5
- 102100035871 Proline, histidine and glycine-rich protein 1 Human genes 0.000 claims 5
- 102100021825 Single-minded homolog 2 Human genes 0.000 claims 5
- 102100029960 Syntaxin-19 Human genes 0.000 claims 5
- 102000003618 TRPM4 Human genes 0.000 claims 5
- 102100029219 Thrombospondin-4 Human genes 0.000 claims 5
- 229920001184 polypeptide Polymers 0.000 claims 5
- 108090000765 processed proteins & peptides Proteins 0.000 claims 5
- 102000004196 processed proteins & peptides Human genes 0.000 claims 5
- 101150029838 ERG gene Proteins 0.000 claims 4
- -1 LOC283177 Proteins 0.000 claims 4
- 239000013068 control sample Substances 0.000 claims 4
- 238000001514 detection method Methods 0.000 claims 4
- 108020004707 nucleic acids Proteins 0.000 claims 4
- 102000039446 nucleic acids Human genes 0.000 claims 4
- 150000007523 nucleic acids Chemical class 0.000 claims 4
- 238000003745 diagnosis Methods 0.000 claims 3
- 230000002018 overexpression Effects 0.000 claims 3
- 238000004393 prognosis Methods 0.000 claims 3
- 210000005267 prostate cell Anatomy 0.000 claims 3
- 239000008280 blood Substances 0.000 claims 2
- 210000004369 blood Anatomy 0.000 claims 2
- 210000002966 serum Anatomy 0.000 claims 2
- 210000001519 tissue Anatomy 0.000 claims 2
- 210000002700 urine Anatomy 0.000 claims 2
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 108020005187 Oligonucleotide Probes Proteins 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 239000002751 oligonucleotide probe Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361921739P | 2013-12-30 | 2013-12-30 | |
| US61/921,739 | 2013-12-30 | ||
| PCT/US2014/072610 WO2015103166A1 (en) | 2013-12-30 | 2014-12-29 | Prostate cancer gene profiles and methods of using the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017509351A JP2017509351A (ja) | 2017-04-06 |
| JP2017509351A5 true JP2017509351A5 (enExample) | 2018-01-25 |
Family
ID=53493959
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016561993A Pending JP2017509351A (ja) | 2013-12-30 | 2014-12-29 | 前立腺癌遺伝子プロファイル及びその使用方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20160326594A1 (enExample) |
| EP (1) | EP3090265B1 (enExample) |
| JP (1) | JP2017509351A (enExample) |
| CN (1) | CN106796236A (enExample) |
| AU (1) | AU2014373927B2 (enExample) |
| CA (1) | CA2934828A1 (enExample) |
| WO (1) | WO2015103166A1 (enExample) |
| ZA (1) | ZA201604370B (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JO3519B1 (ar) | 2013-01-25 | 2020-07-05 | Amgen Inc | تركيبات أجسام مضادة لأجل cdh19 و cd3 |
| WO2017127550A1 (en) * | 2016-01-19 | 2017-07-27 | Wayne State University | Prostate cancer aggressiveness gene signatures for subjects of african or european descent |
| AU2018266632B2 (en) * | 2017-05-12 | 2024-07-25 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine. Inc. | Prostate cancer gene profiles and methods of using the same |
| WO2019169336A1 (en) * | 2018-03-02 | 2019-09-06 | The Johns Hopkins University | Methods for prostate cancer detection |
| CN110054674B (zh) * | 2019-03-07 | 2022-08-05 | 深圳市龙华区人民医院 | 免疫原性多肽以及抗ttc36抗体ap2-19及应用 |
| CN110628908B (zh) * | 2019-09-19 | 2022-05-10 | 北京恩泽康泰生物科技有限公司 | 用于前列腺癌诊断分级和良恶性预测的生物标志物及检测试剂盒 |
| CN111893177B (zh) * | 2020-08-19 | 2022-10-04 | 南通大学 | 遗传性耳聋诱导基因的突变筛选方法及突变检测试剂盒 |
| CN113284559B (zh) * | 2021-07-21 | 2021-10-15 | 暨南大学 | 一种物种基因组的启动子查询方法、系统及设备 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6453242B1 (en) | 1999-01-12 | 2002-09-17 | Sangamo Biosciences, Inc. | Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites |
| US20050032065A1 (en) * | 2002-06-24 | 2005-02-10 | Afar Daniel E. H. | Methods of prognosis of prostate cancer |
| US20040191783A1 (en) * | 2003-03-31 | 2004-09-30 | Guy Leclercq | Low density micro-array analysis in human breast cancer |
| CA2992180C (en) * | 2004-05-07 | 2021-02-23 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Methods of diagnosing or treating prostate cancer using the erg gene, alone or in combination with other over or under expressed genes in prostate cancer |
| US20100143247A1 (en) * | 2004-11-24 | 2010-06-10 | St. George's Enterprises Limited | Diagnosis of prostate cancer |
| CN101310185A (zh) * | 2005-09-19 | 2008-11-19 | 约翰·霍普金斯大学 | 前列腺癌的生物标记 |
| US8338109B2 (en) * | 2006-11-02 | 2012-12-25 | Mayo Foundation For Medical Education And Research | Predicting cancer outcome |
| US20080254481A1 (en) * | 2006-11-13 | 2008-10-16 | Invitrogen Corporation | Methods and kits for detecting prostate cancer biomarkers |
| JP5781922B2 (ja) * | 2008-04-10 | 2015-09-24 | ザ ヘンリー エム．ジャクソン ファウンデーション フォー ザ アドバンスメント オブ ミリタリー メディスン，インコーポレーテッド | Ｅｒｇ遺伝子発現における前立腺癌特異的変化ならびにそれらの変化に基づく検出および治療方法 |
| EP2370813A4 (en) * | 2008-12-04 | 2012-05-23 | Univ California | MATERIALS AND METHODS FOR DIAGNOSIS AND PRESENTATION OF PROSTATE CANCER |
| FR2945820A1 (fr) * | 2009-05-25 | 2010-11-26 | Univ Clermont Auvergne | Panel de genes pour le pronostic du cancer de la prostate |
| CA2795776A1 (en) * | 2010-04-06 | 2011-10-13 | Caris Life Sciences Luxembourg Holdings, S.A.R.L. | Circulating biomarkers for disease |
| ES2925983T3 (es) * | 2010-07-27 | 2022-10-20 | Genomic Health Inc | Método para usar la expresión génica para determinar el pronóstico del cáncer de próstata |
| EP2606353A4 (en) * | 2010-08-18 | 2014-10-15 | Caris Life Sciences Luxembourg Holdings | CIRCULATING BIOMARKERS FOR DISEASES |
| WO2012031008A2 (en) * | 2010-08-31 | 2012-03-08 | The General Hospital Corporation | Cancer-related biological materials in microvesicles |
| EP2514836B1 (en) * | 2011-04-19 | 2016-06-29 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Prostate cancer markers |
| CA2835728A1 (en) * | 2011-05-12 | 2012-11-15 | Noviogendix Research B.V. | Molecular markers in prostate cancer |
| CA2844671A1 (en) * | 2011-08-08 | 2013-02-14 | Caris Life Sciences Luxembourg Holdings, S.A.R.L. | Biomarker compositions and methods |
| JP2014525584A (ja) * | 2011-08-31 | 2014-09-29 | オンコサイト コーポレーション | 癌の治療および診断のための方法および組成物 |
| SE536352C2 (sv) * | 2011-10-24 | 2013-09-03 | Chundsell Medicals Ab | Markörgener för klassificiering av prostatacancer |
| AU2012331104B2 (en) * | 2011-11-04 | 2018-03-15 | Mdxhealth Research B.V. | Combinations of molecular markers in prostate cancer providing a diagnostic tool with improved sensitivity/specificity |
| US9863002B2 (en) * | 2012-06-04 | 2018-01-09 | North Carolina Central University | Genetic determinants of prostate cancer risk |
-
2014
- 2014-12-29 AU AU2014373927A patent/AU2014373927B2/en active Active
- 2014-12-29 WO PCT/US2014/072610 patent/WO2015103166A1/en not_active Ceased
- 2014-12-29 JP JP2016561993A patent/JP2017509351A/ja active Pending
- 2014-12-29 CN CN201480076628.8A patent/CN106796236A/zh active Pending
- 2014-12-29 US US15/108,909 patent/US20160326594A1/en not_active Abandoned
- 2014-12-29 CA CA2934828A patent/CA2934828A1/en not_active Abandoned
- 2014-12-29 EP EP14877549.7A patent/EP3090265B1/en active Active
-
2016
- 2016-06-28 ZA ZA2016/04370A patent/ZA201604370B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017509351A5 (enExample) | ||
| Feng et al. | The implications of single-cell RNA-seq analysis in prostate cancer: unraveling tumor heterogeneity, therapeutic implications and pathways towards personalized therapy | |
| JP2014531573A5 (enExample) | ||
| Wu et al. | MicroRNA-421 is a new potential diagnosis biomarker with higher sensitivity and specificity than carcinoembryonic antigen and cancer antigen 125 in gastric cancer | |
| JP2017507320A5 (enExample) | ||
| Varghese et al. | Identification and clinical implementation of biomarkers for Barrett's esophagus | |
| JP2013500001A5 (enExample) | ||
| WO2008151110A3 (en) | Molecular diagnosis and typing of lung cancer variants | |
| JP2013514074A5 (enExample) | ||
| Zhang et al. | Deep learning promotes profiling of multiple miRNAs in single extracellular vesicles for cancer diagnosis | |
| ES2603956T3 (es) | Método y programa para determinar la sensibilidad a la quimioterapia neoadyuvante para el cáncer de mama | |
| Tao et al. | Predicting the response of neoadjuvant therapy for patients with esophageal carcinoma: an in-depth literature review | |
| Annaratone et al. | Quantification of HER2 and estrogen receptor heterogeneity in breast cancer by single-molecule RNA fluorescence in situ hybridization | |
| Verhaegh et al. | Knowledge-based computational models | |
| HRP20220128T1 (hr) | MARKERI mRNA NA TEMELJU UKUPNE KRVI ZA PREDVIĐANJE RAKA PROSTATE I POSTUPCI ZA OTKRIVANJE ISTOG | |
| US20160326594A1 (en) | Prostate cancer gene profiles and methods of using the same | |
| RU2019104870A (ru) | Комбинированный тест на наличие колоректального рака | |
| Caberlotto et al. | Systems biology meets-omic technologies: novel approaches to biomarker discovery and companion diagnostic development | |
| JP2016073287A (ja) | 腫瘍特性及びマーカーセットの同定のための方法、腫瘍分類、並びに癌のマーカーセット | |
| RU2011134644A (ru) | Способы определения восприимчивости пациента к внутрибольничной инфекции и составления прогноза развития септического синдрома | |
| Pedrazzoli | Currently debated topics on surgical treatment of pancreatic ductal adenocarcinoma: a narrative review on surgical treatment of borderline resectable, locally advanced, and synchronous or metachronous oligometastatic tumor | |
| Ding et al. | Multimodal Artificial Intelligence‐Based Virtual Biopsy for Diagnosing Abdominal Lavage Cytology‐Positive Gastric Cancer | |
| IL317236A (en) | Predicting peptide receptor radiotherapy using gene expression testing | |
| CN105624271A (zh) | 一种与结直肠癌相关的miRNA及其应用 | |
| CA2798434A1 (en) | Discrete states for use as biomarkers |